ADDvise completes the acquisition of Medisuite, LLC

ADDvise Group AB (publ) has today completed the acquisition of all shares in Medisuite, LLC in accordance with the share purchase agreement as previously communicated via a press release on 30 July 2021. Medisuite will be consolidated into ADDvise’s financial reporting as of August 2021. The local management of Medisuite and its operational business structure will remain unchanged pursuant to ADDvise's decentralized structure and the corporate governance of the group. ADDvise welcomes Medisuite to the group.

Advisor

Mangold Fondkommission AB is the financial advisor to ADDvise for the acquisition.

For further information, please contact:

Rikard Akhtarzand, CEO

+46 765-25 90 71

rikard.akhtarzand@addvisegroup.se

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.se.